December 15th, 2015

Pfizer Inc. (NYSE:PFE) ~ Pfizer Expands Clinical Trial Data Access Policy And Launches Data Access Portal

[Business Wire] – Pfizer Inc. today announced an update of its clinical trial data access policy that will simplify and broaden access to information gathered in Pfizer-sponsored clinical trials. Read more on this. . . . → Read More: Pfizer Inc. (NYSE:PFE) ~ Pfizer Expands Clinical Trial Data Access Policy And Launches Data Access Portal Similar posts: Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Sobi’s partner Biogen Idec to present phase 3 data on prolonged half-life of Haemophilia candidates in young children at annual ASH meeting Company Update – Morgan Stanley (NYSE:MS) – Exclusive: U.S. expands China hiring probe to Morgan Stanley AbbVie Inc. (NYSE:ABBV) ~ AbbVie’s hepatitis C treatment helps 96 pct of patients in trial

Pfizer Inc. (NYSE:PFE) [Business Wire] – Pfizer Inc. today announced an update of its clinical trial data access policy that will simplify and broaden access to information gathered in Pfizer-sponsored clinical trials.
Read more on this.

Pfizer Inc. (PFE), with a current value of $202.37B, opened this morning at … [visit site to read more]

Similar posts:
  1. Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Sobi’s partner Biogen Idec to present phase 3 data on prolonged half-life of Haemophilia candidates in young children at annual ASH meeting
  2. Company Update – Morgan Stanley (NYSE:MS) – Exclusive: U.S. expands China hiring probe to Morgan Stanley
  3. AbbVie Inc. (NYSE:ABBV) ~ AbbVie’s hepatitis C treatment helps 96 pct of patients in trial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.